Look for:

REGENERON PHARMACEUTICALS INC.


ISIN:
US75886F1075
WKN:
75886F107

2023/03/24 21:00:01
Price
820.00 USD
Difference 2.22% (17.84)

General attributes

ISINUS75886F1075
SymbolREGN
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)81,046 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)820.01 USD (100)
Ask (Ask size)822.00 USD (100)
Open805.05 USD
High824.00 USD
Low801.01 USD
Close (prev. day)802.16 USD
VWAP816.477891 USD
Volume (pcs)1,129,524
Trading volume922,215,069.63
Number of trades33,875
Last size88,759

Futures and Options

Related Futures-
Related Options-
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2023/03/24 21:00:01
Price
820.00 USD
Difference 2.22% (17.84)

General attributes

ISINUS75886F1075
SymbolREGN
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)81,046 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)820.01 USD (100)
Ask (Ask size)822.00 USD (100)
Open805.05 USD
High824.00 USD
Low801.01 USD
Close (prev. day)802.16 USD
VWAP816.477891 USD
Volume (pcs)1,129,524
Trading volume922,215,069.63
Number of trades33,875
Last size88,759

Performance and Risk

6m1y3y
Perf (%)+17.59%+20.63%+82.41%
Perf (abs.)+122.67+140.24+370.47
Beta0.530.610.57
Volatility28.5534.3332.25
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)778.49 USD (881,266)
Ø price 30 days | Ø volume 30 days (pcs.)760.69 USD (618,219)
Ø price 100 days | Ø volume 100 days (pcs.)745.05 USD (649,426)
Ø price 250 days | Ø volume 250 days (pcs.)690.04 USD (679,139)
YTD High | date824.00 USD (2023/03/24)
YTD Low | date668.00 USD (2023/01/09)
52 Weeks High | date824.00 USD (2023/03/24)
52 Weeks Low | date538.01 USD (2022/06/14)

Arbitrage views

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2023/03/2417:35759.00 EUR0.044
Vienna Stock Exchange2023/03/2417:32759.80 EUR0.003
Tradegate2023/03/2422:26762.80 EUR0.2631
Stuttgart2023/03/2418:16764.40 EUR0.029
Nasdaq2023/03/2421:00820.00 USD922.2233,875
Munich2023/03/2408:04737.40 EUR0.001
London Stock Exchange2023/03/2113:52759.25 USD14.781
Hanover2023/03/2408:59739.20 EUR0.001
Hamburg2023/03/2408:01736.40 EUR0.001
Frankfurt2023/03/2419:52763.90 EUR0.0311
Duesseldorf2023/03/2421:00758.20 EUR0.0012
Berlin2023/03/2408:04737.40 EUR0.001
BX Swiss2023/03/1318:00693.05 CHF0.001

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=99472&ID_TYPE_IMAGE_LOGO=2

Contact Details

REGENERON PHARMACEUTICALS INC.
- -
777 Old Saw Mill River Road - 10591-6707 Tarrytown
Telefon: +1-914-847-7000
Fax: +
E-mail: -

Company Profile

-

Members of Management Board

P. VagelosChairman of Board of Directors
Bonnie BasslerMember of Board of Directors
Craig ThompsonMember of Board of Directors
George YancopoulosMember of Board of Directors
Huda ZoghbiMember of Board of Directors
Joseph GoldsteinMember of Board of Directors
Marc Tessier-LavigneMember of Board of Directors
Michael BrownMember of Board of Directors
N. ColesMember of Board of Directors
Arthur RyanMember of Board of Directors
Christine PoonMember of Board of Directors
George SingMember of Board of Directors
Leonard S. SchleiferChairman of Managing Board
George D. YancopoulosMember of Executive Committee
Robert E. LandryMember of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. For more details please read our Data protection policy.

INFORMATION FOR CORPORATE AND INSTITUTIONAL CLIENTS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.
(iV) It is no consumer.